| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316876 | Clinical Biochemistry | 2018 | 37 Pages |
Abstract
Transference of manufacturer's reported FLC RIs may be inappropriate for select instrument platforms. De novo establishment of FLC RIs specific to instrument platform is highly recommended in order to assure correct patient result classification.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Steven W. Cotten, Zahra Shajani-Yi, Mark A. Cervinski, Timothy Voorhees, Sascha A. Tuchman, Nichole Korpi-Steiner,